The Cardiolipin Antibody (ACL-IgG) test is a blood test that detects the presence of IgG antibodies directed against cardiolipin, a phospholipid found in cell membranes. Elevated levels of these antibodies may indicate an increased risk for autoimmune conditions such as antiphospholipid syndrome, systemic lupus erythematosus, or recurrent miscarriages. This test helps in assessing unexplained blood clotting, thrombosis, or pregnancy complications. ACL-IgG is often measured alongside other antibodies, such as ACL-IgM and lupus anticoagulant, to provide a comprehensive evaluation of autoimmune and thrombotic risk. Results guide clinical management and treatment planning.

• Reports On : With 12 Hours
• Sample Type : Blood
• Fasting : Not Required